BIOMARKER FOR DIAGNOSIS OF GASTRIC CANCER

BIOMARKERS OF FIBROSIS AND USES THEREFOR

RISANKIZUMAB COMPOSITIONS

APPLICATION OF BIOMARKER IN PREPARING METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE CLASSIFICATION PRODUCTS

RELATIVE POTENCY ASSAY FOR VIRAL VECTOR ENCODING ISOMEROHYDROLASES

METHOD, KIT AND DEVICE FOR DETECTING EXTRACELLULAR VESICLES

BIOLOGICAL DEVICES FOR THE DETECTION OF ALZHEIMER'S DISEASE AND CONCUSSIONS AND METHODS OF USE THEREOF

Methods for Sample Quality Assessment

METHOD FOR DETECTING CONTAMINATING CARBOXYLESTERASE ACTIVITY

COMBINATORIAL HIGH-THROUGHPUT SCREENING OF COMPLEX POLYMERIC ENZYME IMMOBILIZATION SUPPORTS

METHOD FOR SCREENING ACETYLCHOLINESTERASE INHIBITOR

METHODS FOR AIDING IN THE DETERMINATION OF WHETHER TO PERFORM IMAGING ON A HUMAN SUBJECT WHO HAS SUSTAINED OR MAY HAVE SUSTAINED AN INJURY TO THE HEAD USING EARLY BIOMARKERS

METHOD FOR RAPIDLY DETECTING PESTICIDE BASED ON THIN-LAYER CHROMATOGRAPHY AND ENZYME INHIBITION PRINCIPLE

METHOD FOR THE DETERMINATION OF HYDROLYTIC ACTIVITY

HIGH THROUGHPUT, FLUORESCENCE-BASED ESTERASE ACTIVITY ASSAY FOR ASSESSING POLYSORBATE DEGRADATION RISK DURING BIOPHARMACEUTICAL DEVELOPMENT

DETECTING SEPSIS

METHOD OF DETECTING VIRUS HAVING HEMAGGLUTININ-ESTERASE ACTIVITY

SELF-IMMOLATIVE PROBES FOR ENZYME ACTIVITY DETECTION

ASSAY FOR RAPID EVALUATION OF CHOROIDAL MAST CELL DEGRANULATION

COLORECTAL CANCER SCREENING EXAMINATION AND EARLY DETECTION METHOD

Senescent cell biomarkers

Sensor, detection method, reagent and kit

ELECTROANALYTICAL DETERMINATION OF LEUKOCYTE ESTERASE

RELATIVE POTENCY ASSAY FOR VIRAL VECTOR ENCODING ISOMEROHYDROLASES

RGO-BASED BIOSENSOR, MANUFACTURING METHOD OF SAME, AND DETECTION METHOD FOR BIOMATERIAL

CES-2 (CARBOXYLESTERASE-2) FOR THE ASSESSMENT OF AFIB RELATED STROKE

COMPOSITIONS AND METHODS FOR DIAGNOSIS OF SHOCK

Methods for aiding in the determination of whether to perform imaging on a human subject who has sustained or may have sustained an injury to the head using early biomarkers

Method for measuring cholesterol in low-density lipoprotein, measurement reagent, and measurement kit

Self-immolative probes for enzyme activity detection

PME-1 AS A BIOMARKER TO PREDICT AND DIAGNOSE AN INCREASED RISK OF ENDOMETRIAL CANCER AND GENE SILENCING OF PME-1 TO INHIBIT EPITHELIAL TO MESENCHYMAL TRANSITION

Senescent cell biomarkers

P-phenylene ethynylene compounds as bioactive and detection agents

Methods for aiding in the determination of whether to perform imaging on a human subject who has sustained or may have sustained an injury to the head using early biomarkers

METHOD FOR QUANTIFYING THE AMOUNT OF CHOLESTEROL IN HIGH-DENSITY LIPOPROTEIN 3

DETECTING SEPSIS

Method for the diagnosis of etoposide prodrug treatable cancer

COMPOSITIONS AND METHODS FOR DIAGNOSIS OF SHOCK

Compositions and methods for detecting and quantifying host cell protein in cell lines and recombinant polypeptide products

Compositions and methods for detecting and quantifying host cell protein in cell lines and recombinant polypeptide products

USES OF LP-PLA2 IN COMBINATION TO ASSESS CORONARY RISK

Immunoassay test slide

OBSTRUCTIVE SLEEP APNEA (OSA) BIOMARKER PANEL

Enrichment and selective culture of and

BIOMARKERS FOR PREDICTING DEGREE OF WEIGHT LOSS IN MALE SUBJECTS

SCREENING ASSAYS BASED ON MAG AND/OR ABHD6 FOR SELECTING INSULIN SECRETION PROMOTING AGENT

Reagent kit used for detecting lipoprotein-associated phospholipase A2, and preparation method and application for reagent kit

Method for Detecting Human Butyrylcholinesterase

Molecular sensor and methods of use thereof

PME-1 as a biomarker to predict and diagnose an increased risk of endometrial cancer and gene silencing of PME-1 to inhibit epithelial to mesenchymal transition

Senescent cell biomarkers

THERMOSTABILIZATION OF PROTEINS

P-phenylene ethynylene compounds as bioactive and detection agents

Red-shifted luciferins and methods of using same

Detection of the degree of exposure to chemical warfare nerve agents and organophosphate pesticides with lateral flow assays

NOVEL LUNG CANCER BIOMARKER (LIPH)

Systems and methods for analyzing an extracted sample using an immiscible extraction solvent

BIOMARKERS FOR CARDIOVASCULAR DISEASE

VALUE-ASSIGNED SOLUTIONS OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 HAVING A LONG SHELF-LIFE

Compositions and methods for detecting and quantifying host cells protein in cell lines and recombinant polypeptide products

Use of at least one substrate of carboxylesterase and/or triacylglycerol lipase for detecting bacteria of the group

Method of reducing accumulation of intracellular tingible body macrophages

PROTECTION OF TCR SIGNALING CHAINS IN CANCER PATIENTS AND ENHANCEMENT OF CAR-T CELL THERAPY

Fluorogenic/fluorescent probes derivative from sulfoxanthene, and use thereof

PARAOXONASE 1 ENZYMATIC ACTIVITY, A RISK PREDICTOR FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS

GHRELIN IN THE DIAGNOSIS OF CNS DISORDERS

Homogenous thermal shift ligand binding assay

Protein biosensors, cross reactive sensor arrays and methods of use thereof

PME-1 as a biomarker to predict and diagnose endometrial and breast cancer and gene silencing of PME-1 to inhibit epithelial to mesenchymal transition

Molecular sensor and methods of use thereof

Methods for detecting LP-PLA2 activity and inhibition of LP-PLA2 activity

Method for measuring cholesterol in high-density lipoprotein

Method of selecting individualized brain cancer therapy

MOLECULAR DIAGNOSTIC ASSAY DEVICE AND METHOD OF USE

Cancer Diagnosis by Measuring Polyisoprenylated Methylated Protein Methyl Esterase Activity

COMBINATION OF SPLA2 ACTIVITY AND LP(A) CARDIOVASCULAR RISK FACTORS FOR THE DIAGNOSIS/PROGNOSIS OF A CARDIOVASCULAR DISEASE/EVENT

LONG SHELF-LIFE KITS AND METHODS FOR STANDARDIZING, VERIFYING, CALIBRATING OR RECALIBRATING DETECTION OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2

Anti-sPLA2-IIA antibodies and uses thereof

METHODS FOR DETECTING LP-PLA2 ACTIVITY AND INHIBITION OF LP-PLA2 ACTIVITY

Method of selecting analyte to samples using a lateral flow device

Thermostabilization of proteins

PME-1 as a biomarker to predict and diagnose an increased risk of endometrial cancer and gene silencing of PME-1 to inhibit epithelial to mesenchymal transition

Immunoassay test slide

Cancer phospholipidome

Monoclonal antibodies which specifically recognize human liver-carboxylesterase 1, hybridoma cell lines which produce monoclonal antibodies, and uses thereof

Method for quantification of remnant-like lipoprotein cholesterol and kit for same

PLA2G16 as a target for antiviral compounds

Reagents and methods for sirtuin capture

Compositions and Methods for Effecting the Levels of High Density Lipoprotein (HDL) Cholesterol and Apolipoprotein AI, Very Low Density Lipoprotein (VLDL) Cholesterol and Low Density Lipoprotein (LDL) Cholesterol

Screening Method

Material for removing cauxin in cat urine

ASSAY FOR PHYTOL-FREE CHLOROPHYLL DERIVATIVES

Combination of sPLA2 type IIA mass and OXPL/APOB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event

Method of diagnosing renal dysfunction in a cat based on non-cauxin protein levels

Methods of diagnosing a plasmodium infection

Methods for detecting LP-PLA2 activity and inhibition of LP-PLA2 activity

SERUM SPLA2-IIA AS DIAGNOSIS MARKER FOR PROSTATE AND LUNG CANCER

COMBINATION OF SPLA2 ACTIVITY AND LP(A) CARDIOVASCULAR RISK FACTORS FOR THE DIAGNOSIS/PROGNOSIS OF A CARDIOVASCULAR DISEASE/EVENT

METHODS AFFECTING MARKERS IN PATIENTS HAVING VASCULAR DISEASE

Combination of sPLA2 activity and oxPL/apoB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event

KITS FOR ASSAYING ENZYME-MEDIATED OXIDATIVE DEMETHYLATION

Screening Method

Lysosomal phospholipase A2 (LPLA2) activity as a therapeutic target for treating systemic lupus erythematosus

Compositions and Methods for Diagnosis of Shock

LIPASE POLYPEPTIDE

Lipoprotein lipase assay

METHOD

Enzymatic Assay for the Quantitative Determination of Phospholipase A1 or A2 Activity in a Sample

METHODS AFFECTING MARKERS IN PATIENTS HAVING VASCULAR DISEASE

Combination of sPLA2 activity and OxPL/apoB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event

OXIDIZED PARAOXONASE 1 AND PARAOXONASE 1/HDL PARTICLE NUMBER RATIO AS RISK MARKERS FOR CARDIOVASCULAR DISEASE

Method of inhibiting prostate cancer cell proliferation

Method for screening of substance which alter GPR120-mediated cell-stimulating activities

Diagnostics for membranous nephropathy

Thermostabilization of proteins

Plasma biomarker tool for the diagnosis of liver cancer comprising liver carboxylesterase 1 and liver cancer screening method

Uses of Lp-PLA2 in combination to assess coronary risk

Carboxylesterase-1 Polymorphisms and Methods of Use Therefor

Methods and compositions for modulating hair growth

Method of using lipid acyltransferase

CALCIUM FLUX AS A PHARMACOEFFICACY BIOMARKER FOR INHIBITORS OF HISTONE DEACETYLASE

Compounds and methods of use thereof for assaying lysophospholipase D activity

Methods for detecting Lp-PLA2 activity and inhibition of Lp-PLA2 activity

Methods

Method of screening substance useful in treating disease with the use of GPR40 and phospholipase

Diagnostic kit for detecting urinary protein of a cat after cauxin removal

Method of assaying enzyme-mediated oxidative demethylation

FUNCTIONAL EXPRESSION OF TRIACYLGYLCEROL LIPASES

Whole blood assay

HOMO-DOUBLY LABELED COMPOSITIONS FOR THE DETECTION OF ENZYME ACTIVITY IN BIOLOGICAL SAMPLES

Lysosomal phospholipase A2 (LPLA2) activity as a diagnostic and therapeutic target for identifying and treating systemic lupus erythematosis

Methods and compositions for determing a level of biologically active serum paraoxonase

Crystal structure of monoacylglycerol lipase (MGLL)

MODULATORS OF PROTEIN PHOSPHATASE 2A AND PP2A METHYL ESTERASE

Method for measuring activity of a specific fraction of albumin

Method for measuring triglyceride in low-density lipoprotein

PARAOXONASE 1 ENZYMATIC ACTIVITY, A RISK INDICATOR FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS

Compositions and Methods for Effecting the Levels of High Density Lipoprotein (HDL) Cholesterol and Apolipoprotein AI, Very Low Density Lipoprotein (VLDL) Cholesterol and Low Density Lipoprotein (LDL) Cholesterol

Methods for treating diseases having an inflammatory component related to phospholipase A2

Suppression of sPLA2-integrin binding for treating an inflammatory condition

Compounds and methods of use thereof for assaying lysophospholipase D activity

Reduced RDM-1 gene expression in plants

Method

Antibodies that bind canine pancreatic lipase

Microtitration plates comprising wells coated with a lipid substrate and a method of preparing

Bioassay element and producing method thereof

Method of inhibiting prostate cancer cell proliferation

Uses of selective inhibitors of HDAC8 for treatment of T-cell proliferative disorders

METHODS AND COMPOSITIONS FOR COUPLED LUMINESCENT ASSAYS

Modulators of protein phosphatase 2A and PP2A methyl esterase

Identification of Phospholipase A2 as Target in Cancer Treatment, with Special Emphasis on Colorectal Cancer and Its Mechanism of Action

Methods Of Detecting Lp-PLA2 Activity

Method and Test-Kit for the Detection and Quantification of Organisms

Diagnosis and prognosis of wound infection by measurement of a phospholipase Ain wound fluid

Novel lipase

Methods for detecting lp-pla2 activity and inhibition of lp-pla2 activity

Method for producing active and stable acetylcholinesterase bioassay element

Detection of secreted lipase proteins from Candida species

Method of using lipid acyltransferase

Method for releasing a product comprising chemical oxidation, method for detecting said product and uses thereof

Electronic device for communication with living cells

Uses of lp-pla2 in combination to assess coronary risk

Peptide having hydrolase activity

High throughput assay of Lp-PLA2 activity

Methods affecting markers in patients having vascular disease

Method of using lipid acyltransferase

Hydrolytic substrates for an analyte-dependent enzyme activation system

Identification of adiponutrin-related proteins as esterases and methods of use for the same

Methods and devices for detecting pancreatic lipase

Novel uses of antibodies against AChE and peptides thereof

Compositions and methods for effecting the levels of high density lipoprotein (HDL) cholesterol and apolipoprotein Al, very low density lipoprotein (VLDL) cholesterol and low density lipoprotein (LDL) cholesterol

Method of using lipid acyltransferase

Method

Used of inhibitors of phospholipase a2 for the treatment, prevention or diagnosis of neural inflammatory or demyelinating disease

Method

Methods and compositions for using aleveolar macrophage phospholipase A2

Screening methods for the identification of agents that inhibit SIRT1 Tat deacetylase activity

Pullulanase variants and methods for preparing such variants with predetermined properties

Methods and compositions for using alveolar macrophage phospholipase A2

Methods for detecting Lp-PLA2 activity and inhibition of Lp-PLA2 activity

Peptidyl-tRNA hydrolase of Enterococcus faecalis

Methods to determine the presence or amount of canine pancreatic lipase with antibodies

Isolated human lipase proteins, nucleic acid molecules encoding human lipase proteins, and uses thereof

Homo-doubly labeled compositions for the detection of enzyme activity in biological samples

Compounds

Compounds for determining the activity of phospholipase A

Method for quantitating triglycerides in lipoproteins

Test strip for determining concentration of multiple analytes in a single fluid sample

Detection of cholinesterase inhibition with microfluidic devices and systems thereof

Gradient elution moving boundary electrophoresis for use with complex samples and detection of toxins

Compositions and methods for treating concussion

Gradient elution moving boundary electrophoresis for use with complex samples and detection of toxins